ATLASEloxx Pharmaceuticals (ELOX) earnings date: Nov 10, 2026
Eloxx Pharmaceuticals (ELOX) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 10, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ELOX
| Last price | $13.07 (-2.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.1% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Eloxx Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Eloxx Pharmaceuticals reports on Nov 10, 2026. One email the day before, with ATLAS’s read on Eloxx Pharmaceuticals. You can switch it off at any time.
Alert me before ELOX reportsFree to start. Creating an account takes under a minute.
Notify me when Eloxx Pharmaceuticals reports
Track ELOX free Add Eloxx Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
ELOX earnings at a glance
| Next report (confirmed) | Tue, Nov 10, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Mar 5, 2026 · Miss |
| Beat rate (last 3 reports) | 1 of 3 (33%) |
| Average EPS surprise | -2.9% |
| Average move around a report | ±9.7% (last 3) |
| Sector | Healthcare · Biotechnology |
Eloxx Pharmaceuticals earnings history: last 3 reports
Eloxx Pharmaceuticals last reported on Mar 5, 2026: EPS of $0.57 against an estimate of $0.67 (-14.9% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Mar 5, 2026 | $0.67 | $0.57 | -14.9% | Miss | 0.0% |
| Nov 12, 2023 | -$1.97 | -$1.31 | +33.5% | Beat | -7.2% |
| Aug 10, 2023 | -$1.54 | -$1.96 | -27.3% | Miss | -21.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ELOX
See the fair value, the probability range and the earnings history of Eloxx Pharmaceuticals on its ATLAS page.
Eloxx Pharmaceuticals (ELOX) stock analysisPlans from €3.99 a month.
Eloxx Pharmaceuticals earnings: frequently asked questions
When does Eloxx Pharmaceuticals (ELOX) report earnings?
Eloxx Pharmaceuticals is scheduled to report on Tuesday, November 10, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does ELOX beat earnings estimates?
Of its last 3 reports with a recorded result, Eloxx Pharmaceuticals beat the EPS estimate 1 times; the average surprise was -2.9%. Past results do not predict the next one.
How much does ELOX move around earnings?
Over its last 3 reports the stock moved an average of 9.7% (absolute, from the close before the report day to the close after it), and finished higher 0 of 3 times.
Did Eloxx Pharmaceuticals beat earnings estimates last quarter?
Eloxx Pharmaceuticals last reported on Mar 5, 2026: EPS of $0.57 against an estimate of $0.67 (-14.9% surprise), a miss.
How much does ELOX usually move in a day?
On a normal trading day the ATLAS model puts ELOX’s one-day range at about ±6.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 10, 2026
Educational information, not investment advice. Disclaimer